Syncom Form Peer Comparison

NSE: SYNCOMF | BSE: 524470

₹21.41

₹-0.54 (-2.46%)

As on 19-Oct-2026IST

Market cap

₹2,013 Cr

Revenue (TTM)

₹498 Cr

P/E Ratio

23.5

P/B Ratio

4.6

Div. Yield

0.5 %

Edit

	Syncom Form	Shilpa Medicare	Caplin Point Lab	Pfizer	Eris Lifesciences
Market cap (₹ Cr)	2,013	17,132	17,194	17,417	15,618
Revenue (₹ Cr)	498	1,682	2,287	2,570	3,230
Net Profit (₹ Cr)	85.53	273.51	678.07	735.15	666.92
Net Margin (%)	16.11	16.19	28.10	26.88	20.60
RoE (%)	21.56	11.15	19.73	19.16	18.75
Price to Earnings	23.54	57.62	25.84	23.69	24.25
Price-To-Book	4.58	6.38	4.68	3.95	3.87

Income Statement (₹ Cr)

	Syncom Form	Shilpa Medicare	Caplin Point Lab	Pfizer	Eris Lifesciences
Operating Revenue	497.80	1,682.47	2,287.33	2,569.77	3,229.67
Total Income	530.93	1,689.83	2,413.29	2,735.39	3,237.12
Total Expenditure	409.97	1,203.91	1,490.75	1,628.14	2,090.06
EBITDA	87.83	478.55	796.58	941.63	1,139.61
Depreciation	6.73	126.01	78.10	57.58	281.06
EBIT	81.10	352.55	718.48	884.05	858.55
Interest	1.15	52.11	0.88	7.69	190.64
Other Income	33.13	7.37	125.96	165.62	7.45
Exceptional Items	0.00	12.16	0.00	-49.16	-17.24
Profit before Tax	113.08	319.96	843.56	992.82	658.12
Provision for Tax	27.55	46.45	165.49	257.67	-8.80
Profit after Tax	85.53	273.51	678.07	735.15	666.92

	Syncom Form	Shilpa Medicare	Caplin Point Lab	Pfizer	Eris Lifesciences
Shareholder's Funds	414.99	2,591.20	3,586.42	4,202.90	3,902.67
Minority Interest	0.00	0.00	-12.71	0.00	-21.81
Non-Current Liabilities	15.13	266.35	28.74	91.50	1,392.75
Current Liabilities	103.73	848.06	385.94	627.48	2,077.10
Total Liabilities	536.32	3,705.61	4,037.51	4,921.88	7,246.72

	Syncom Form	Shilpa Medicare	Caplin Point Lab	Pfizer	Eris Lifesciences
Non-Current Assets	186.05	2,525.44	1,291.22	770.28	5,617.77
Current Assets	330.37	1,109.77	2,585.66	3,803.22	1,539.85
Total Assets	536.32	3,705.61	4,037.51	4,921.88	7,246.72
Total Debt*	1.47	657.97	0.57	2.50	2,309.68
Net Current Assets	226.64	261.71	2,199.72	3,175.74	-537.25
Contingent Liabilities	0.78	160.01	17.53	370.49	51.57

	Syncom Form	Shilpa Medicare	Caplin Point Lab	Pfizer	Eris Lifesciences
Cash From Operating Activities	58.08	342.18	523.24	967.57	537.99
Cash Flow from Investing Activities	-50.62	-325.92	-582.30	-561.67	-369.46
Cash from Financing Activities	-3.02	13.62	-46.46	-798.31	-313.53
Net Cash Inflow / Outflow	4.44	29.88	-105.52	-392.41	-145.00

	Syncom Form	Shilpa Medicare	Caplin Point Lab	Pfizer	Eris Lifesciences
ROCE (%)	26.80	11.43	24.97	23.39	14.47
ROE (%)	21.56	11.15	19.73	19.16	18.75
ROA (%)	18.06	7.80	18.69	14.95	9.26
EBIT Margin (%)	16.29	20.95	31.41	34.40	26.58
Net Margin (%)	16.11	16.19	28.10	26.88	20.60
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	0.00

	Syncom Form	Shilpa Medicare	Caplin Point Lab	Pfizer	Eris Lifesciences
Revenue Growth (%)	0.44	27.91	15.01	10.69	9.59
EBIT Growth (%)	46.88	58.32	18.45	24.14	16.84
Net Profit Growth (%)	48.61	149.56	19.61	-9.09	62.68
EPS Growth (%)	48.71	-3.57	17.73	14.40	67.41
Book Value Growth (%)	21.29	9.67	26.75	-0.34	36.71

	Syncom Form	Shilpa Medicare	Caplin Point Lab	Pfizer	Eris Lifesciences
Price / Earnings	23.54	61.12	25.84	22.58	23.64
Price / Book Value	4.58	6.38	4.68	3.95	3.87
Dividend Yield (%)	0.47	0.07	0.35	1.97	0.00
EV/EBITDA	21.66	37.08	20.32	15.20	15.67
Market Cap (₹ Cr)	968.22	6,819.66	11,439.22	21,592.90	17,980.08

	Syncom Form	Shilpa Medicare	Caplin Point Lab	Pfizer	Eris Lifesciences
Debt to Equity	0.00	0.07	0.00	0.00	0.24
Short term debt to equity ratio	0.00	0.16	0.00	0.00	0.12
Current Ratio	3.18	1.31	6.70	6.06	0.74
Quick Ratio	2.58	0.88	5.59	5.31	0.53
Interest Coverage	99.42	7.14	959.59	130.11	4.45

	Syncom Form	Shilpa Medicare	Caplin Point Lab	Pfizer	Eris Lifesciences
Debtors to sales (%)	22.20	30.84	36.10	7.07	21.07
Asset Turnover	1.05	0.48	0.63	0.52	0.45
Receivable days	81.35	113.81	121.68	26.06	63.88
Inventory Days	38.88	84.76	63.83	65.95	43.27
Payable days	91.02	101.94	108.28	81.01	151.85
Cash Conversion Cycle	29.21	96.62	77.23	11.00	-44.70

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.